Drug Shortage Report for STRENSIQ
| Report ID | 126791 |
| Drug Identification Number | 02444623 |
| Brand name | STRENSIQ |
| Common or Proper name | ASFOTASE ALFA |
| Company Name | ALEXION PHARMA GMBH |
| Market Status | MARKETED |
| Active Ingredient(s) | ASFOTASE ALFA |
| Strength(s) | 40MG |
| Dosage form(s) | SOLUTION |
| Route of administration | SUBCUTANEOUS SUBCUTANEOUS |
| Packaging size | 2ML, 3ML |
| ATC code | A16AB |
| ATC description | OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2021-03-01 |
| Actual start date | |
| Estimated end date | |
| Actual end date | 2021-10-28 |
| Shortage status | Resolved |
| Updated date | 2021-11-02 |
| Company comments | 28mg/0.7mL (40mg/mL) presentation |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | NEUHOFSTRASSE 34 BAAR, -- SWITZERLAND 6340 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v13 | 2021-11-02 | French | Compare |
| v12 | 2021-11-02 | English | Compare |
| v11 | 2021-09-13 | French | Compare |
| v10 | 2021-09-13 | English | Compare |
| v9 | 2021-03-02 | English | Compare |
| v8 | 2020-12-03 | French | Compare |
| v7 | 2020-12-03 | English | Compare |
| v6 | 2020-10-21 | French | Compare |
| v5 | 2020-10-21 | English | Compare |
| v4 | 2020-10-21 | French | Compare |
| v3 | 2020-10-21 | English | Compare |
| v2 | 2020-10-21 | French | Compare |
| v1 | 2020-10-21 | English | Compare |
Showing 1 to 13 of 13